Cargando…

Outcomes in infants with unprovoked venous thromboembolism: A retrospective cohort study

BACKGROUND: Although children aged <1 year have a relatively high rate of venous thromboembolism (VTE) compared to older children, most have additional prothrombotic risk factors. Unprovoked VTE is rare, and little is known about this population, particularly the risk of recurrent VTE. OBJECTIVES...

Descripción completa

Detalles Bibliográficos
Autores principales:	Whitworth, Hilary, Beslow, Lauren A., Hubbard, Rebecca A., Leonard, Charles E., Scobell, Rebecca, Witmer, Char, Raffini, Leslie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394551/ https://www.ncbi.nlm.nih.gov/pubmed/37538506 http://dx.doi.org/10.1016/j.rpth.2023.100174

Ejemplares similares

Extended anticoagulation for unprovoked venous thromboembolism
por: Castellucci, Lana A., et al.
Publicado: (2018)

Screening for cancer in unprovoked venous thromboembolism
por: Shivji, Salma, et al.
Publicado: (2019)

Should lifelong anticoagulation for unprovoked venous thromboembolism be revisited?
por: Moodley, Otto, et al.
Publicado: (2015)

Pediatric Hospital Acquired Venous Thromboembolism
por: Witmer, Char M., et al.
Publicado: (2017)

Genetic Risk Profiling Associated with Recurrent Unprovoked Venous Thromboembolism
por: Hodeib, Hossam, et al.
Publicado: (2021)

Management of Patients With Unprovoked Venous Thromboembolism: An Evidence-Based and Practical Approach
por: Marcucci, Maura, et al.
Publicado: (2013)

Validation of a prognostic score for hidden cancer in unprovoked venous thromboembolism
por: Jara-Palomares, Luis, et al.
Publicado: (2018)

Clinical outcomes of prolonged anticoagulation with rivaroxaban after unprovoked venous thromboembolism
por: Berger, Jeffrey S., et al.
Publicado: (2017)

Case Report: Unprovoked venous thromboembolism in a young adult male
por: Dhabhar, Jeyhan, et al.
Publicado: (2019)

Provoked versus unprovoked venous thromboembolism: Findings from GARFIELD‐VTE
por: Ageno, Walter, et al.
Publicado: (2021)

The prevalence and clinical manifestation of hereditary thrombophilia in Korean patients with unprovoked venous thromboembolisms
por: Lee, Su Yeon, et al.
Publicado: (2017)

Long‐Term Effects of Unprovoked Venous Thromboembolism on Mortality and Major Cardiovascular Events
por: Chang, Wei‐Ting, et al.
Publicado: (2017)

Exploring Opportunities for Primary Prevention of Unprovoked Venous Thromboembolism: Ready for Prime Time?
por: Folsom, Aaron R., et al.
Publicado: (2020)

Predicting major bleeding during extended anticoagulation for unprovoked or weakly provoked venous thromboembolism
por: Wells, Philip S., et al.
Publicado: (2022)

Impact of D-Dimer for Prediction of Incident Occult Cancer in Patients with Unprovoked Venous Thromboembolism
por: Han, Donghee, et al.
Publicado: (2016)

Rivaroxaban Treatment for Patients With Unprovoked or Provoked Venous Thromboembolism　― Subanalysis of the J’xactly Study ―
por: Hisatake, Shinji, et al.
Publicado: (2022)

CT imaging for occult malignancy in patients with unprovoked venous thromboembolism (VTE) in a tertiary centre: is it worthwhile?
por: Lee, Ronan J., et al.
Publicado: (2023)

Practical Considerations for Use of Direct Oral Anticoagulants in Children
por: Whitworth, Hilary, et al.
Publicado: (2022)

Prevention of Hospital-Acquired Venous Thromboembolism in Children: A Review of Published Guidelines
por: Faustino, E. Vincent S., et al.
Publicado: (2017)

Acute myocardial infarction after initially diagnosed with unprovoked venous thromboembolism: A case report
por: Seo, Jeongduk, et al.
Publicado: (2023)

Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis
por: Khan, Faizan, et al.
Publicado: (2019)

Systematic review of prognostic models for recurrent venous thromboembolism (VTE) post-treatment of first unprovoked VTE
por: Ensor, Joie, et al.
Publicado: (2016)

D-dimer and reduced-dose apixaban for extended treatment after unprovoked venous thromboembolism: the Apidulcis study
por: Palareti, Gualtiero, et al.
Publicado: (2022)

Thrombotic events in critically ill children with coronavirus disease 2019 or multisystem inflammatory syndrome in children
por: Dain, Aleksandra S., et al.
Publicado: (2022)

Reduced proliferation of endothelial colony-forming cells in unprovoked venous thromboembolic disease as a consequence of endothelial dysfunction
por: Hernandez-Lopez, Rubicel, et al.
Publicado: (2017)

Predictive Value for Increased Red Blood Cell Distribution Width in Unprovoked Acute Venous Thromboembolism at the Emergency Department
por: Febra, Cláudia, et al.
Publicado: (2023)

Screening for cancer in patients with unprovoked venous thromboembolism: protocol for a systematic review and individual patient data meta-analysis
por: van Es, Nick, et al.
Publicado: (2017)

Outcomes beyond the Third Month of Anticoagulation in Patients Aged >75 Years with a First Episode of Unprovoked Venous Thromboembolism
por: Iñurrieta, Amaia, et al.
Publicado: (2018)

Risk scores for occult cancer in patients with unprovoked venous thromboembolism: Results from an individual patient data meta‐analysis
por: Mulder, Frits I., et al.
Publicado: (2020)

Protocol for a modelling study to assess the clinical and cost-effectiveness of indefinite anticoagulant therapy for first unprovoked venous thromboembolism
por: Khan, Faizan, et al.
Publicado: (2023)

Protocol for a systematic review of prognostic models for the recurrence of venous thromboembolism (VTE) following treatment for a first unprovoked VTE
por: Ensor, Joie, et al.
Publicado: (2013)

Cancer Screening in Patients with Unprovoked Thromboembolism: How to do it and Who Benefits?
por: Ferreira, Filipa, et al.
Publicado: (2020)

Correction: Screening for cancer in patients with unprovoked venous thromboembolism: protocol for a systematic review and individual patient data meta-analysis
Publicado: (2017)

Antithrombotic therapy for secondary prevention of unprovoked venous thromboembolism: a systematic review and network meta-analysis of randomized controlled trials
por: Li, Dandan, et al.
Publicado: (2022)

Three Cases of Unprovoked Venous Thromboembolism with Prothrombin p.Arg596Gln Variant and a Literature Review of Antithrombin Resistance
por: Tsuji, Akihiro, et al.
Publicado: (2022)

Extensive Unprovoked Thromboembolism in Steroid-Dependent Ulcerative Colitis: A Case Report
por: Arshad, Hassaan, et al.
Publicado: (2023)

Risk of major bleeding during extended oral anticoagulation in patients with first unprovoked venous thromboembolism: a systematic review and meta-analysis protocol
por: Khan, Faizan, et al.
Publicado: (2019)

Long-term risk of recurrence after discontinuing anticoagulants for a first unprovoked venous thromboembolism: protocol for a systematic review and meta-analysis
por: Khan, Faizan, et al.
Publicado: (2017)

Positron Emission Tomography Combined With Computed Tomography as a Screening Tool for Occult Malignancy in Patients With Unprovoked Venous Thromboembolism: An Observational Study
por: Chauchard, Maria, et al.
Publicado: (2014)

Safety and Efficacy of Rivaroxaban for Extended-Phase Anticoagulation of Patients with Unprovoked or Recurrent Venous Thromboembolism: Real-Life Data from the MAC Project
por: Bortoluzzi, Cristiano, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_54am8oa3d8q2fgdtp18kcptrs6